landiolol

FDA Drug Profile — RAPIBLYK

landiolol is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including RAPIBLYK. Available dosage form: injection, powder, lyophilized, for solution.

Drug details

Generic Name
landiolol
Brand Names
RAPIBLYK
Application Number
NDA217202
Sponsor
AOP Orphan Pharmaceuticals GmbH
NDC Codes
2
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients
LANDIOLOL HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE RAPIBLYK is indicated for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter, and pediatric patients with supraventricular tachycardia. RAPIBLYK is a beta adrenergic blocker indicated for the short-term reduction of ventricular rate in: adults with supraventricular tachycardia including atrial fibrillation and atrial flutter ( 1 ), and pediatric patients with supraventricular tachycardia.( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.